Archive · 23 Jul 2025
US-Funded Mpox Vaccines Face Expiration, Lawmakers Warn
The US government bought a lot of mpox vaccines, which is a disease that causes flu-like symptoms and sores.
Some of these vaccines are sitting in warehouses and might expire, meaning they won't be useful anymore.
Democratic members of Congress are worried because these vaccines, paid for with taxpayers' money, could be wasted.
They wrote a letter to the State Department, saying it's a bad idea to let these vaccines go to waste.
The government hasn't responded yet, but the situation highlights the importance of using resources efficiently to prevent illness.
Hundreds of thousands of US-funded mpox vaccine doses may expire.
Democratic House members sent a letter to the State Department expressing concern.
The vaccines are at risk of going to waste in warehouses.
Up to 800,000 doses could be at risk, while 220,000 doses may be viable.
Congressional Democrats view the potential waste as a moral and strategic failure.
- Who
- Dozens of Democratic House members are concerned.
- What
- Hundreds of thousands of mpox vaccine doses may expire.
- When
- Not specified, but an issue raised in a recent letter.
- Where
- The vaccines are in warehouses intended for African nations.
- Why
- To prevent the waste of taxpayer money and address a potential public health issue.
Democratic House Members
N/A
Vaccine Waste
Democratic House Members
Concerned about potential waste of taxpayer funds.
N/A
N/A
- Vaccine Type
- Mpox
- Number of Doses at Risk
- Up to 800,000
- Potentially Viable Doses
- 220,000
- Concerned Parties
- Democratic House members
- Recipient Location
- African nations
- Primary Issue
- Risk of expiration